Is time to progression associated with post-progression survival in previously treated metastatic non-small cell lung cancer with BRAF V600E mutation? A secondary analysis of phase II clinical trial data

OBJECTIVE: Longer time to progression (TTP) is associated with prolonged post-progression survival (PPS) in anaplastic lymphoma kinase+non-small cell lung cancer (NSCLC). This study evaluated whether TTP is associated with PPS among previously treated patients with metastatic v-Raf murine sarcoma vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Junlong, Sasane, Medha, Zhang, Jie, Zhao, Jing, Ricculli, Marie Louise, Yao, Zhiwen, Redhu, Suman, Signorovitch, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104743/
https://www.ncbi.nlm.nih.gov/pubmed/30121602
http://dx.doi.org/10.1136/bmjopen-2018-021642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104743/
https://www.ncbi.nlm.nih.gov/pubmed/30121602
http://dx.doi.org/10.1136/bmjopen-2018-021642

Ejemplares similares